These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
283 related items for PubMed ID: 8516203
1. [Clinical evaluation of gliquidone--short acting sulfonylurea derivative--comparison with glibenclamide and gliclazide]. Rupprecht E, König E, Limmer J. Pol Tyg Lek; 1993 Apr; 48 Suppl 1():31-2. PubMed ID: 8516203 [No Abstract] [Full Text] [Related]
3. [Experience with diamicron treatment of diabetics]. Velikov VK, Shubina IO, Saltykov BB, Frolova AI. Klin Med (Mosk); 1984 Nov; 62(11):99-101. PubMed ID: 6441072 [No Abstract] [Full Text] [Related]
4. Are sulphonylureas all the same? A cohort study on cardiovascular and cancer-related mortality. Monami M, Balzi D, Lamanna C, Barchielli A, Masotti G, Buiatti E, Marchionni N, Mannucci E. Diabetes Metab Res Rev; 2007 Sep; 23(6):479-84. PubMed ID: 17385195 [Abstract] [Full Text] [Related]
7. Beneficial effects of gliclazide modified release compared with glibenclamide on endothelial activation and low-grade inflammation in patients with type 2 diabetes. Räkel A, Renier G, Roussin A, Buithieu J, Mamputu JC, Serri O. Diabetes Obes Metab; 2007 Jan; 9(1):127-9. PubMed ID: 17199728 [No Abstract] [Full Text] [Related]
8. Comparison of diabetic control in type 2 (non-insulin dependent) diabetic patients treated with different sulphonylureas. Harrower AD. Curr Med Res Opin; 1985 Jan; 9(10):676-80. PubMed ID: 3935376 [Abstract] [Full Text] [Related]
10. Potentiating effects of combined usage of three sulfonylurea drugs on the occurrence of alloxan diabetes in rats. Katsumata K, Katsumata Y, Ozawa T, Katsumata K. Horm Metab Res; 1993 Feb; 25(2):125-6. PubMed ID: 8458609 [No Abstract] [Full Text] [Related]
11. Glibenclamide vs gliclazide in reducing oxidative stress in patients of noninsulin dependent diabetes mellitus--a double blind randomized study. Chugh SN, Dhawan R, Kishore K, Sharma A, Chugh K. J Assoc Physicians India; 2001 Aug; 49():803-7. PubMed ID: 11837468 [Abstract] [Full Text] [Related]
15. [Free radical scavenging activity of sulfonylureas: a clinical assessment of the effectiveness of gliclazide]. Jennings PE, Belch JJ. Ter Arkh; 2001 Jun 20; 73(4):27-31. PubMed ID: 11494442 [Abstract] [Full Text] [Related]
16. Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients. Bo S, Castiglione A, Ghigo E, Gentile L, Durazzo M, Cavallo-Perin P, Ciccone G. Eur J Endocrinol; 2013 Jul 20; 169(1):117-26. PubMed ID: 23660643 [Abstract] [Full Text] [Related]
17. Effects of glimepiride and glibenclamide on carotid atherosclerosis in type 2 diabetic patients. Katakami N, Kaneto H, Matsuhisa M, Shimomura I, Yamasaki Y. Diabetes Res Clin Pract; 2011 Apr 20; 92(1):e20-2. PubMed ID: 21257219 [Abstract] [Full Text] [Related]